☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
pharma
MIRA Pharmaceuticals & MIRALOGX Entered into an Exclusive Licensing Agreement for Ketamir-2
November 21, 2023
Boundless Bio Entered into a Clinical Trial Collaboration and Supply Agreement with Taiho Oncology to Evaluate Lytgobi + BBI-355 f...
September 19, 2023
Free Webinar: Beyond the Horizon: Exploring Competitive Insights in the Life Science and Pharma Sectors
September 4, 2023
Pharma Tech Conclave 2023
February 22, 2023
Pharma IPR Conference 2023: The 12th Annual Pharma Intellectual Property Rights
January 30, 2023
Intas Entered into an Exclusive License Agreement with Syna to Commercialize Biosimilar LB-0702
November 3, 2022
Load more...
Back to Home